A Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies
Open Access
- 6 June 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 7 (1), 1-17
- https://doi.org/10.1038/s41598-017-02325-8
Abstract
The innate immune system of humans and other mammals responds to pathogen-associated molecular patterns (PAMPs) that are conserved across broad classes of infectious agents such as bacteria and viruses. We hypothesized that a blood-based transcriptional signature could be discovered indicating a host systemic response to viral infection. Previous work identified host transcriptional signatures to individual viruses including influenza, respiratory syncytial virus and dengue, but the generality of these signatures across all viral infection types has not been established. Based on 44 publicly available datasets and two clinical studies of our own design, we discovered and validated a four-gene expression signature in whole blood, indicative of a general host systemic response to many types of viral infection. The signature’s genes are: Interferon Stimulated Gene 15 (ISG15), Interleukin 16 (IL16), 2′,5′-Oligoadenylate Synthetase Like (OASL), and Adhesion G Protein Coupled Receptor E5 (ADGRE5). In each of 13 validation datasets encompassing human, macaque, chimpanzee, pig, mouse, rat and all seven Baltimore virus classification groups, the signature provides statistically significant (p < 0.05) discrimination between viral and non-viral conditions. The signature may have clinical utility for differentiating host systemic inflammation (SI) due to viral versus bacterial or non-infectious causes.Keywords
This publication has 116 references indexed in Scilit:
- Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung CancersPLOS ONE, 2013
- A genomic storm in critically injured humansThe Journal of Experimental Medicine, 2011
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- Immunomodulation of caprine lentiviral infection by interleukin-16Comparative Immunology, Microbiology and Infectious Diseases, 2010
- Identification of high-quality cancer prognostic markers and metastasis network modulesNature Communications, 2010
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Time course differential gene expression in response to porcine circovirus type 2 subclinical infectionVeterinary Research, 2009
- Gene Expression Signatures Diagnose Influenza and Other Symptomatic Respiratory Viral Infections in HumansCell Host & Microbe, 2009
- ISG15 Inhibits Nedd4 Ubiquitin E3 Activity and Enhances the Innate Antiviral Response*Published by Elsevier BV ,2008
- ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activityProceedings of the National Academy of Sciences of the United States of America, 2008